CoChat

Low lipoprotein(a) levels and risk of disease in a large, contemporary, general population study

Langsted, Anne, Nordestgaard, Børge G, Kamstrup, Pia R · 2021 · European Heart Journal

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

Aims: With the current focus on lipoprotein(a) as a likely causal risk factor for cardiovascular disease and new drugs potentially on the market to lower lipoprotein(a) levels, the safety of lowering lipoprotein(a) to low levels becomes increasingly important. We tested whether low levels of lipoprotein(a) and corresponding LPA genotypes associate with major disease groups including cancers and infectious disease. Methods and results: We included 109 440 individuals from the Copenhagen General Population Study. For main World Health Organization International Classification of Diseases 10th edition chapter diseases, the only concordant association of low levels of lipoprotein(a) plasma levels and corresponding LPA genotypes with risk of disease was with low risk of diseases of the circulatory system. Furthermore, no concordant association of low levels of lipoprotein(a) plasma levels and corresponding LPA genotypes with the risk of any cancer (i.e. cancer subtypes combined) or infectious disease was seen. The hazard ratio for the risk of any cancer was 1.06 [95% confidence interval (CI): 0.97–1.15] for the first vs. the fourth quartile of lipoprotein(a), 1.02 (0.97–1.07) for the fourth vs. the first quartile of KIV-2 number of repeats, and 1.01 (0.96–1.07) for rs10455872 non-carriers vs. carriers. The corresponding hazard ratios for the risk of hospitalization for infection were 1.05 (95% CI: 0.99–1.10), 1.02 (0.98–1.07), and 0.97 (0.93–1.03), respectively. Conclusion: In a large, contemporary, general population cohort, apart from the well-established association with cardiovascular disease, low levels of lipoprotein(a) and corresponding LPA genotypes did not concordantly associate with any major disease groups including cancers and infections. There is no safety signal from our results to indicate that low levels of lipoprotein(a) are harmful.

Overview

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehaa1085

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 39 references

Cited by

See all 78

Metadata

Authors
Langsted, A., Nordestgaard, B. G., & Kamstrup, P. R.
Affiliations
  • University of Copenhagen (DK)
  • Herlev Hospital (DK)
Corresponding author
Kamstrup, Pia R
Venue
European Heart Journal
Published
2021-01-22
Volume
42
Issue
12
Pages
1147-1156
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W3136144822
Cited by
72
References
39
Citations by year
2026: 6 · 2025: 16 · 2024: 11 · 2023: 14 · 2022: 17 · 2021: 8
FWCI
8.90
Type
journal article
Language
en
Open access
closed
Locations
  • European Heart Journal (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
  • Danish Medical Research Council
  • Danish Heart Foundation
  • Copenhagen County Foundation
  • Herlev and Gentofte Hospital
  • Copenhagen University Hospital
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords
lipoprotein(a), LPA gene, rs10455872, cardiovascular disease, cancer risk, infectious diseases, hospitalization, drug safety, Copenhagen General Population Study
MeSH terms
Cardiovascular Diseases, Genotype, Humans, Risk Factors, Lipoprotein(a)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Low lipoprotein(a) levels and risk of disease in a large, contemporary, general population study. https://app.cochat.ai/papers/10.1093/eurheartj/ehaa1085
The paper
Langsted, A., Nordestgaard, B. G., & Kamstrup, P. R. (2021). Low lipoprotein(a) levels and risk of disease in a large, contemporary, general population study. European Heart Journal. https://doi.org/10.1093/eurheartj/ehaa1085

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.